DermTech, Inc.
DMTKQ · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2% | 0.2% | -1.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 18.5% | 11.2% | 4.4% | 0.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -496.8% | -469.1% | -471.6% | -770.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -520.4% | -486.5% | -489.5% | -788% |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 |
| % Growth | -3.6% | 1.8% | 42.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |